| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Molecular and Clinical Endocrinology and Oncology (F.O., T.C., L.V., G.L., A.C.), Obstetrics and Gynecology (A.T.), and Clinical Medicine (F.G., C.V.), Cardiovascular and Immunological Sciences, Cardiac Rehabilitation Unit, University "Federico II" Naples, 80131 Naples, Italy; Department of Obstetrics and Gynecology (S.P., T.R.), University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy; and Gastroenterology Unit (F.M.), "Cardarelli" Hospital, 80131 Naples, Italy
Address all correspondence and requests for reprints to: Francesco Orio, M.D., Ph.D., Department of Molecular, Clinical Endocrinology, and Oncology, University "Federico II" of Naples, Via S. Pansini 5, 80131 Naples, Italy. E-mail: francescoorio{at}virgilio.it.
Context: Insulin resistance is a feature of polycystic ovary syndrome (PCOS), and it is related to mitochondrial function, particularly with maximal oxygen consumption (VO2max). At the moment, no evaluation of cardiopulmonary functional capacity in young patients with PCOS has been performed.
Objective: Our objective was to assess cardiopulmonary functional capacity in young PCOS overweight patients.
Design and Setting: We conducted a prospective baseline-controlled clinical study at University "Federico II" of Naples, School of Medicine (Naples, Italy).
Patients: Forty-five PCOS patients were matched with 45 healthy women for age (mean ± SD, 21.3 ± 2.0 vs. 21.6 ± 1.9 yr, respectively) and body mass index (29.4 ± 3.6 vs. 29.0 ± 3.4 kg/m2, respectively).
Mean Outcome Measures: We assessed hormonal and metabolic pattern and functional capacity by cardiopulmonary exercise testing to evaluate maximal oxygen consumption (VO2max), oxygen consumption at anaerobic threshold (VO2AT), and the maximal workload at peak exercise.
Results: VO2max (17.0 ± 3.7 vs. 26.8 ± 3.5 ml/kg·min), oxygen consumption at anaerobic threshold (13.9 ± 3.0 vs. 21.2 ± 3.8 ml/kg·min), and maximal workload at peak exercise (101.3 ± 25.2 vs. 135 ± 22.6 W) were significantly (P < 0.001) reduced in PCOS subjects compared with healthy women. The multiple linear regression analysis showed that only homeostasis model assessment appears to have a strong negative linear relation with VO2max in PCOS. No relation was found in controls.
Conclusions: Our data demonstrate a reduced cardiopulmonary functional capacity in young PCOS patients.
This article has been cited by other articles:
![]() |
V. M. Victor, M. Rocha, C. Banuls, M. Sanchez-Serrano, E. Sola, M. Gomez, and A. Hernandez-Mijares Mitochondrial Complex I Impairment in Leukocytes from Polycystic Ovary Syndrome Patients with Insulin Resistance J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3505 - 3512. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Palomba, A. Falbo, F. Zullo, and F. Orio Jr. Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review Endocr. Rev., February 1, 2009; 30(1): 1 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Skov, D. Glintborg, S. Knudsen, T. Jensen, T. A. Kruse, Q. Tan, K. Brusgaard, H. Beck-Nielsen, and K. Hojlund Reduced Expression of Nuclear-Encoded Genes Involved in Mitochondrial Oxidative Metabolism in Skeletal Muscle of Insulin-Resistant Women With Polycystic Ovary Syndrome Diabetes, September 1, 2007; 56(9): 2349 - 2355. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Orio, F. Manguso, S. Di Biase, A. Falbo, F. Giallauria, D. Labella, A. Tolino, G. Lombardi, A. Colao, and S. Palomba Metformin administration improves leukocyte count in women with polycystic ovary syndrome: a 6-month prospective study Eur. J. Endocrinol., July 1, 2007; 157(1): 69 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vigorito, F. Giallauria, S. Palomba, T. Cascella, F. Manguso, R. Lucci, A. De Lorenzo, D. Tafuri, G. Lombardi, A. Colao, et al. Beneficial Effects of a Three-Month Structured Exercise Training Program on Cardiopulmonary Functional Capacity in Young Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1379 - 1384. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |